CMS Intestinal and Multi-Visceral Transplantation Coverage Policy Updated: What Billing Teams Need to Know (NCD 280)

CMS has issued a modification to National Coverage Determination 280, governing Medicare coverage for intestinal and multi-visceral transplantation. This update, effective March 12, 2026, reaffirms and clarifies the conditions under which Medicare will cover these complex, high-cost procedures — and billing teams at transplant centers need to verify their documentation processes align with every requirement before claims go out the door.

What CMS NCD 280 Covers: Intestinal and Multi-Visceral Transplantation for Medicare Patients

The Centers for Medicare & Medicaid Services covers intestinal and multi-visceral transplantation under two benefit categories: Inpatient Hospital Services and Physicians' Services. Coverage exists for one defined purpose — restoring intestinal function in patients with irreversible intestinal failure.

CMS defines intestinal failure as the loss of absorptive capacity of the small bowel secondary to severe primary gastrointestinal disease or surgically induced short bowel syndrome. Multi-visceral transplantation — which may include the stomach, duodenum, pancreas, liver, and intestine — falls under this same NCD when performed to address this condition.

A key policy note relevant to billing: CMS explicitly declined to build in an age exclusion. The policy acknowledges that older patients generally have lower survival rates than younger recipients, but UNOS data shows some older patients without other contraindications progress well post-transplant. Billing teams should not assume a Medicare patient's age alone is a denial trigger under this policy.

CMS TPN Failure Criteria: The Core Medical Necessity Requirement

Coverage under NCD 280 requires that the patient has failed total parenteral nutrition (TPN) before transplantation. This is non-negotiable — the policy language is explicit that coverage is available only for patients who have failed TPN. TPN failure is not a general statement; CMS defines four specific clinical scenarios that constitute failure:

1. Impending or overt liver failure due to TPN-induced liver injury. Documentation should include clinical findings such as elevated serum bilirubin and/or liver enzymes, splenomegaly, thrombocytopenia, gastroesophageal varices, coagulopathy, stomal bleeding, or hepatic fibrosis/cirrhosis.

2. Thrombosis of two or more major central venous channels. Affected vessels include the jugular, subclavian, and femoral veins. CMS identifies this as a life-threatening complication. Sequelae documented in the policy include lack of TPN access, fatal sepsis from infected thrombi, pulmonary embolism, Superior Vena Cava syndrome, and chronic venous insufficiency.

3. Frequent line infection and sepsis. The threshold is two or more episodes of systemic sepsis secondary to line infection per year requiring hospitalization. A single episode of line-related fungemia, septic shock, or Acute Respiratory Distress Syndrome also qualifies as a TPN failure indicator.

4. Frequent severe dehydration episodes. This applies despite IV fluid supplementation in addition to TPN, under conditions such as secretory diarrhea or a non-constructable GI tract. The policy specifically calls out the risk of kidney stones, renal failure, and permanent brain damage as downstream consequences that support medical necessity.

Every claim submitted under this policy needs to map back to at least one of these four criteria with specific supporting documentation. Vague references to "TPN intolerance" won't hold up in an audit.

Facility Approval Requirements Under NCD 280

Intestinal transplantation Medicare coverage isn't just about the patient — it's also conditional on where the procedure is performed. CMS will only cover these transplants when performed at an approved facility. The approval criteria are:

• Volume threshold: A minimum of 10 intestinal transplants per year
• Survival benchmark: A one-year actuarial survival rate of at least 65%, calculated using the Kaplan-Meier technique

If your facility is performing intestinal or multi-visceral transplants but has not formally confirmed CMS approval status, claims are at serious risk of denial regardless of how well-documented the patient's TPN failure is. Facility approval must be verified and maintained — this isn't a one-time credentialing checkbox.

Non-Covered Indications: What CMS Explicitly Excludes

NCD 280 is narrow by design. CMS has stated plainly that all other indications for intestinal or multi-visceral transplantation remain non-covered under Medicare. There is no gray area here — if the clinical scenario doesn't fit the irreversible intestinal failure definition combined with documented TPN failure, Medicare coverage does not apply.

Billing teams should flag any case where the transplant indication deviates from this framework before the claim is built. Pursuing coverage for non-covered indications creates audit exposure and clean claim rate problems downstream.

Affected Codes

The policy document for NCD 280 does not list specific CPT, HCPCS, or ICD-10 codes. Billing teams should work directly with their coding department to identify the appropriate procedure codes for intestinal and multi-visceral transplantation, and confirm mapping against the CMS Claims Processing Instructions referenced in the NCD (Transmittal 966). When the policy is silent on codes, internal coding validation and payer LCD cross-referencing become even more critical.

What Your Billing Team Should Do